Page results
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
Diet and nutrition advice for people experiencing weight loss, weight gain, appetite changes, difficulty eating, or other digestive problems which have happened as a result of their treatment or condition. Advice is also available for people who are confused about what diet or nutrition advice to follow.
-
Advice for University College London Hospital patients who have experienced hair loss.
-
Anaemia is a condition in which the body has fewer red blood cells, or have less haemoglobin in the red blood cells, than normal. Patients who may have anaemia can be referred to general haematology by GPs and hospital doctors.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
UCLH treats a range of red cell blood disorders and anaemias.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
This page is for patients who are receiving radiotherapy to the bladder.
-
Spinal tumours can cause pressure on the spinal cord and/or nerves and depending on where the tumour is in your spine, different areas of your body can be affected.
-
The London Sarcoma Service is one of the largest sarcoma services in Europe with an international reputation for providing the highest quality of care to patients with sarcoma.
File results
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023